Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Pilot Study to Evaluate the Efficacy and Safety of Raptiva (Efalizumab)in Combination With Narrow Band Phototherapy for the Treatment of Moderate to Severe Plaque Psoriasis.

NCT00302445 is registered in ClinicalTrials.gov with Derm Research, PLLC as lead sponsor.

NCT NCT00302445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00302445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Pilot Study to Evaluate the Efficacy and Safety of Raptiva (Efalizumab)in Combination With Narrow Band Phototherapy for the Treatment of Moderate to Severe Plaque Psoriasis.
Lead sponsor
Derm Research, PLLC
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2006
Completion date
July 31, 2007
Enrollment
20
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis